Trial Profile
Multicentre study in US liver transplant centres of the combination of simeprevir and sofosbuvir in patients with hepatitis C genotype 1 who are ineligible, previously intolerant or non-responsive to interferon-based therapy
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Dec 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 07 Dec 2015 New trial record